2026. Review: Methods of synthesis of erlotinib and its derivatives as tyrosine kinase inhibitor in 2020-2025. Journal Port Science Research. 9, 1 (Jan. 2026), 12–30. DOI:https://doi.org/10.36371/port.2026.1.2.